Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNew weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho's Dan DolevMatt Taylor, Jefferies analyst, and Dan Dolev, managing director at Mizuho Securities, join 'The Exchange' to discuss how new weight loss drugs could decline revenue for restaurant transaction platforms Toast Tab, and how weight loss drugs could reduce the need for medical devices.
Persons:
Dan Dolev Matt Taylor, Dan Dolev
Organizations:
Jefferies, Mizuho Securities